Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain

NCT02634788 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

322

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: Buprenorphine
DRUG: Placebo

Sponsor

INSYS Therapeutics Inc